Multiple Sclerosis Drug Market - Top Companies and Manufacturers

  • Report ID: 1986
  • Published Date: Jul 22, 2024
  • Report Format: PDF, PPT

Companies Dominating the Multiple Sclerosis Drug Landscape

top-features-companies
    • Biogen
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG
    • Sanofi
    • Teva Pharmaceutical Industries Ltd.
    • Merck KGaA.
    • Janssen Pharmaceuticals Companies of Johnson & Johnson
    • Bristol-Myers Squibb Company
    • Cipla Inc. 

Browse Key Market Insights with Data Illustration:

In the News

  • Janssen Pharmaceutical Companies announced the approval of PONVORY by the U.S. Food and Drug Administration. Ponvory is an oral medication used for treating adults with relapsing multiple Sclerosis.
  • Biogen collaborated with Eisai Co., Ltd., for the co-promotion of multiple sclerosis treatments including Tecfidera, Tysabri, and Avonex in Japan.


Author Credits:  Radhika Pawar


  • Report ID: 1986
  • Published Date: Jul 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of multiple sclerosis drug is estimated at USD 24.82 Billion.

The multiple sclerosis drug market size was over USD 23.94 Billion in 2023 and is projected to cross USD 40.37 Billion by the end of 2036, growing at more than 4.1% CAGR during the forecast period i.e., between 2024-2036. Factors such as, higher prevalence of multiple sclerosis, advancement in research and development, higher instances of women having multiple sclerosis and government efforts for the treatment is to drive the market growth.

North America industry is anticipated to hold largest share by 2036, impelled by rising burden of multiple sclerosis among the population and a higher probability of women getting multiple sclerosis in the region.

Biogen, Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd., Merck KGaA., Janssen Pharmaceuticals Companies of Johnson & Johnson, Bristol-Myers Squibb Company, Cipla Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying